High-Quality Mobilized Leukopaks to Enhance Your Cell and Gene Therapy Research and Development
Learn about mobilized leukopaks, CD34+ cell isolation, and cutting-edge techniques in cell and gene therapy research with STEMCELL Technologies.
Arrayed CRISPR screening for phenotypic discovery at the MRC-AstraZeneca-University of Cambridge Joint Functional Genomics Screening Laboratory (FGSL)
The FGSL aims to form collaborations to advance our understanding of development and disease mechanism through functional interrogation of the genome at scale.
The Cancer-Immunity Cycle: Methods, Challenges, and Opportunities
In this series, experts provide an overview of technologies, techniques, challenges, and emerging research questions along each step of the cancer immunity cycle.
#ExpertAnswers: Marta Walasek and Danielle Nguyen Truong on Stem Cells
Marta Walasek and Danielle Nguyen Truong provide tips and tricks to lock down effective genome editing conditions for CD34+ cells, methods to evaluate genome editing efficiency, and optimal culture conditions to maintain Hematopoeitic stem cell function and long-term editing effects.
Optimizing Cell Therapy Research Workflows
A 2-part mini series from STEMCELL Technologies highlighting optimized products, protocols, and workflows for cell therapy research.
Optimizing CD34+ Cell Genome Editing for Efficiency and HSPC Maintenance
Experts provide tips and tricks to lock down effective genome editing conditions for CD34+ cells, methods to evaluate genome editing efficiency, and optimal culture conditions to maintain HSPC function and long-term editing effects.
